EP1333860A4 - Antibodies to the propeptide of candida albicans and methods of use - Google Patents

Antibodies to the propeptide of candida albicans and methods of use

Info

Publication number
EP1333860A4
EP1333860A4 EP01979303A EP01979303A EP1333860A4 EP 1333860 A4 EP1333860 A4 EP 1333860A4 EP 01979303 A EP01979303 A EP 01979303A EP 01979303 A EP01979303 A EP 01979303A EP 1333860 A4 EP1333860 A4 EP 1333860A4
Authority
EP
European Patent Office
Prior art keywords
propeptide
antibodies
methods
candida albicans
albicans
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP01979303A
Other languages
German (de)
French (fr)
Other versions
EP1333860A1 (en
Inventor
Margaret K Hostetter
Denise Devore-Carter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yale University
Original Assignee
Yale University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yale University filed Critical Yale University
Publication of EP1333860A1 publication Critical patent/EP1333860A1/en
Publication of EP1333860A4 publication Critical patent/EP1333860A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/14—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from fungi, algea or lichens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56961—Plant cells or fungi
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/37—Assays involving biological materials from specific organisms or of a specific nature from fungi
    • G01N2333/39—Assays involving biological materials from specific organisms or of a specific nature from fungi from yeasts
    • G01N2333/40—Assays involving biological materials from specific organisms or of a specific nature from fungi from yeasts from Candida

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Botany (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
EP01979303A 2000-09-28 2001-09-28 Antibodies to the propeptide of candida albicans and methods of use Withdrawn EP1333860A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23708200P 2000-09-28 2000-09-28
US237082P 2000-09-28
PCT/US2001/030312 WO2002026257A1 (en) 2000-09-28 2001-09-28 Antibodies to the propeptide of candida albicans and methods of use

Publications (2)

Publication Number Publication Date
EP1333860A1 EP1333860A1 (en) 2003-08-13
EP1333860A4 true EP1333860A4 (en) 2005-08-10

Family

ID=22892264

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01979303A Withdrawn EP1333860A4 (en) 2000-09-28 2001-09-28 Antibodies to the propeptide of candida albicans and methods of use

Country Status (5)

Country Link
EP (1) EP1333860A4 (en)
JP (1) JP2004509923A (en)
AU (1) AU2002211279A1 (en)
CA (1) CA2423797A1 (en)
WO (1) WO2002026257A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1812063A4 (en) * 2004-10-29 2009-02-11 Univ Yale Monoclonal antibodies to the propeptide of candida albicans and methods of use

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5886151A (en) * 1996-05-03 1999-03-23 Regents Of The University Of Minnesota Candida albicans integrin-like protein

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2657495A (en) * 1994-05-23 1995-12-18 Research And Development Institute, Inc. Candida albicans adhesin as a vaccine

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5886151A (en) * 1996-05-03 1999-03-23 Regents Of The University Of Minnesota Candida albicans integrin-like protein

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
GALE C A ET AL: "Linkage of adhesion, filamentous growth and virulence in candida albicans to a single gene, INT1", SCIENCE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE,, US, vol. 279, 27 February 1998 (1998-02-27), pages 1355 - 1358, XP002954887, ISSN: 0036-8075 *
See also references of WO0226257A1 *

Also Published As

Publication number Publication date
CA2423797A1 (en) 2002-04-04
EP1333860A1 (en) 2003-08-13
JP2004509923A (en) 2004-04-02
WO2002026257A1 (en) 2002-04-04
AU2002211279A1 (en) 2002-04-08

Similar Documents

Publication Publication Date Title
ZA200305825B (en) Modified antibodies and methods of use
AU8390301A (en) Antibodies to human MCP-1
HK1050013A1 (en) ANTIBODIES TO HUMAN IL-1β
TWI316088B (en) Anti-tnf alpha antibodies and their uses
HUS1300015I1 (en) Antibodies to human il-1beta
HUP0302105A3 (en) Structural member for use in the construction of buildings
IL150886A0 (en) Physiolgical sample collection devices and methods of using the same
HK1060727A1 (en) Antagonists of mcp-1 function and methods of use thereof
IL184144A0 (en) Intermediates useful in the preparaiton of 2-aminocarbonyl-9h-purine derivatives
HK1060728A1 (en) Antagonists of mcp-1 function and methods of use thereof
SG94850A1 (en) Method to achieve low and stable ferromagnetic coupling field
AU9290601A (en) Characterization of the gsk-3beta protein and methods of use thereof
EP1336998A4 (en) Electrochemical device and method of manufacturing the device
HK1038796B (en) Method of earth-resistance measurement
AU2608602A (en) Silensed anti-cd28 antibodies and use thereof
AU1334602A (en) Osteopontin-coated surfaces and methods of use
GB0025312D0 (en) Methods and means for modification of plant characteristics
EP1369689A4 (en) Immunoassay method and immunoassay reagent kit to be used therein
FI20000194A0 (en) The method of trading
EP1263935A4 (en) Scytonemin and methods of using thereof
EP1333860A4 (en) Antibodies to the propeptide of candida albicans and methods of use
AU2001261496A1 (en) Luxo-sigma54 interactions and methods of use
EP1812063A4 (en) Monoclonal antibodies to the propeptide of candida albicans and methods of use
GB2368059B (en) Tubular container and method of manufacture thereof
GB0016625D0 (en) Article of soap of the like and method of manufacture thereof

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20030424

AK Designated contracting states

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

RIC1 Information provided on ipc code assigned before grant

Ipc: 7C 07K 16/14 B

Ipc: 7G 01N 33/53 B

Ipc: 7A 61K 39/40 B

Ipc: 7A 61K 39/395 A

A4 Supplementary search report drawn up and despatched

Effective date: 20050617

17Q First examination report despatched

Effective date: 20080424

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20100511